Median admission blood glucose levels 244 mg/dL (IQR 166–368 mg/dL) for patients receiving insulin detemir and 226 mg/dL (IQR 172–314 mg/dL) for patients receiving insulin glargine (p = 0.61) were present even though most were known to have diabetes mellitus. The gene discussed is INS; the disease is diabetes mellitus.